vs

Side-by-side financial comparison of CORCEPT THERAPEUTICS INC (CORT) and Stitch Fix, Inc. (SFIX). Click either name above to swap in a different company.

Stitch Fix, Inc. is the larger business by last-quarter revenue ($342.1M vs $202.1M, roughly 1.7× CORCEPT THERAPEUTICS INC). CORCEPT THERAPEUTICS INC runs the higher net margin — 12.0% vs -1.9%, a 13.9% gap on every dollar of revenue. On growth, CORCEPT THERAPEUTICS INC posted the faster year-over-year revenue change (11.1% vs 7.3%). CORCEPT THERAPEUTICS INC produced more free cash flow last quarter ($38.4M vs $5.6M). Over the past eight quarters, CORCEPT THERAPEUTICS INC's revenue compounded faster (17.3% CAGR vs 1.8%).

Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Corcept has focused on the adverse effects of excess cortisol, studying new compounds that may mitigate those effects. Its executive team is headed by CEO, president and director Joseph K. Belanoff, MD.

Stitch Fix, Inc. is an online personal styling service in the United States. It uses recommendation algorithms and data science to personalize clothing items based on size, budget and style. The company was founded in 2011 and had an initial public offering in 2017 with a valuation of $1.6 billion. Stitch Fix generated $1.6 billion in net revenue in its fiscal year 2023, a decrease of 21% year-over-year and reported 3,297,000 active clients in September 2023. It is headquartered in San Franci...

CORT vs SFIX — Head-to-Head

Bigger by revenue
SFIX
SFIX
1.7× larger
SFIX
$342.1M
$202.1M
CORT
Growing faster (revenue YoY)
CORT
CORT
+3.8% gap
CORT
11.1%
7.3%
SFIX
Higher net margin
CORT
CORT
13.9% more per $
CORT
12.0%
-1.9%
SFIX
More free cash flow
CORT
CORT
$32.8M more FCF
CORT
$38.4M
$5.6M
SFIX
Faster 2-yr revenue CAGR
CORT
CORT
Annualised
CORT
17.3%
1.8%
SFIX

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CORT
CORT
SFIX
SFIX
Revenue
$202.1M
$342.1M
Net Profit
$24.3M
$-6.4M
Gross Margin
98.7%
43.6%
Operating Margin
2.2%
-2.5%
Net Margin
12.0%
-1.9%
Revenue YoY
11.1%
7.3%
Net Profit YoY
-21.0%
-1.7%
EPS (diluted)
$0.20
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CORT
CORT
SFIX
SFIX
Q4 25
$202.1M
$342.1M
Q3 25
$207.6M
$311.2M
Q2 25
$194.4M
$325.0M
Q1 25
$157.2M
$312.1M
Q4 24
$181.9M
$318.8M
Q3 24
$182.5M
$319.6M
Q2 24
$163.8M
$322.7M
Q1 24
$146.8M
$330.4M
Net Profit
CORT
CORT
SFIX
SFIX
Q4 25
$24.3M
$-6.4M
Q3 25
$19.7M
$-8.6M
Q2 25
$35.1M
$-7.4M
Q1 25
$20.5M
$-6.5M
Q4 24
$30.7M
$-6.3M
Q3 24
$47.2M
$-36.5M
Q2 24
$35.5M
$-21.3M
Q1 24
$27.8M
$-35.5M
Gross Margin
CORT
CORT
SFIX
SFIX
Q4 25
98.7%
43.6%
Q3 25
97.8%
43.6%
Q2 25
98.2%
44.2%
Q1 25
98.5%
44.5%
Q4 24
98.4%
45.4%
Q3 24
98.4%
44.6%
Q2 24
98.5%
45.5%
Q1 24
98.3%
43.4%
Operating Margin
CORT
CORT
SFIX
SFIX
Q4 25
2.2%
-2.5%
Q3 25
4.9%
-3.6%
Q2 25
13.7%
-3.0%
Q1 25
2.2%
-2.9%
Q4 24
13.9%
-2.8%
Q3 24
25.5%
-13.1%
Q2 24
21.7%
-7.7%
Q1 24
20.1%
-11.5%
Net Margin
CORT
CORT
SFIX
SFIX
Q4 25
12.0%
-1.9%
Q3 25
9.5%
-2.8%
Q2 25
18.1%
-2.3%
Q1 25
13.1%
-2.1%
Q4 24
16.9%
-2.0%
Q3 24
25.9%
-11.4%
Q2 24
21.7%
-6.6%
Q1 24
18.9%
-10.8%
EPS (diluted)
CORT
CORT
SFIX
SFIX
Q4 25
$0.20
$-0.05
Q3 25
$0.16
$-0.06
Q2 25
$0.29
$-0.06
Q1 25
$0.17
$-0.05
Q4 24
$0.25
$-0.05
Q3 24
$0.41
$-0.29
Q2 24
$0.32
$-0.18
Q1 24
$0.25
$-0.30

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CORT
CORT
SFIX
SFIX
Cash + ST InvestmentsLiquidity on hand
$372.2M
$244.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$647.8M
$204.1M
Total Assets
$836.7M
$530.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CORT
CORT
SFIX
SFIX
Q4 25
$372.2M
$244.2M
Q3 25
$421.7M
$234.9M
Q2 25
$342.2M
$234.2M
Q1 25
$322.8M
$219.1M
Q4 24
$383.3M
$253.3M
Q3 24
$380.3M
$247.0M
Q2 24
$473.2M
$244.5M
Q1 24
$410.8M
$229.8M
Stockholders' Equity
CORT
CORT
SFIX
SFIX
Q4 25
$647.8M
$204.1M
Q3 25
$631.9M
$203.0M
Q2 25
$635.8M
$200.4M
Q1 25
$683.3M
$197.8M
Q4 24
$679.6M
$190.5M
Q3 24
$638.8M
$187.0M
Q2 24
$596.2M
$208.9M
Q1 24
$547.9M
$213.3M
Total Assets
CORT
CORT
SFIX
SFIX
Q4 25
$836.7M
$530.7M
Q3 25
$823.6M
$480.6M
Q2 25
$801.7M
$484.7M
Q1 25
$846.5M
$472.6M
Q4 24
$840.6M
$507.1M
Q3 24
$784.3M
$486.9M
Q2 24
$714.6M
$537.0M
Q1 24
$655.9M
$538.3M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CORT
CORT
SFIX
SFIX
Operating Cash FlowLast quarter
$38.4M
$10.9M
Free Cash FlowOCF − Capex
$38.4M
$5.6M
FCF MarginFCF / Revenue
19.0%
1.6%
Capex IntensityCapex / Revenue
0.0%
1.6%
Cash ConversionOCF / Net Profit
1.58×
TTM Free Cash FlowTrailing 4 quarters
$4.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CORT
CORT
SFIX
SFIX
Q4 25
$38.4M
$10.9M
Q3 25
$54.5M
$7.0M
Q2 25
$43.9M
$20.5M
Q1 25
$5.1M
$-16.2M
Q4 24
$59.3M
$14.3M
Q3 24
$73.8M
$8.2M
Q2 24
$41.2M
$21.7M
Q1 24
$23.8M
$-22.3M
Free Cash Flow
CORT
CORT
SFIX
SFIX
Q4 25
$38.4M
$5.6M
Q3 25
$2.8M
Q2 25
$43.9M
$16.0M
Q1 25
$5.0M
$-19.4M
Q4 24
$59.2M
$9.9M
Q3 24
$72.2M
$4.5M
Q2 24
$40.8M
$18.9M
Q1 24
$-26.1M
FCF Margin
CORT
CORT
SFIX
SFIX
Q4 25
19.0%
1.6%
Q3 25
0.9%
Q2 25
22.6%
4.9%
Q1 25
3.2%
-6.2%
Q4 24
32.5%
3.1%
Q3 24
39.5%
1.4%
Q2 24
24.9%
5.9%
Q1 24
-7.9%
Capex Intensity
CORT
CORT
SFIX
SFIX
Q4 25
0.0%
1.6%
Q3 25
0.0%
1.4%
Q2 25
0.0%
1.4%
Q1 25
0.1%
1.0%
Q4 24
0.1%
1.4%
Q3 24
0.9%
1.2%
Q2 24
0.3%
0.9%
Q1 24
0.0%
1.1%
Cash Conversion
CORT
CORT
SFIX
SFIX
Q4 25
1.58×
Q3 25
2.77×
Q2 25
1.25×
Q1 25
0.25×
Q4 24
1.93×
Q3 24
1.56×
Q2 24
1.16×
Q1 24
0.86×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons